Table 3.
Poisson regression summary table of rate ratios (RR) for effects of vaping and smoking frequencies on respiratory symptoms stratified by smoking statusa, Canada, 2020–2021
|
Non-smokers only
|
Ever smokers only
|
Daily smokers only
|
All participants
|
Among current vapers (device type analysis)
|
|
|---|---|---|---|---|---|
| RR (95% CI) | RR (95% CI) | RR (95% CI) | RR (95% CI) | RR (95% CI) | |
| Pack-equivalent yearsb | 11.36 (4.61–28.00)*** | 2.79 (1.69–4.61)*** | 0.84 (0.23–3.11)*** | 2.29 (1.41–371)*** | 2.20 (1.34–3.61)** |
| Smoking status | |||||
| Ever smoker (Ref.) | |||||
| Daily smoker | 1.47 (1.24–1.73)*** | 1.53 (1.29-1.82) | |||
| Never smoker | 0.68 (0.61–0.76)*** | 0.75 (0.66–0.85)*** | |||
| Interactions | |||||
| Daily smoker X pack-equivalent years | 0.41 (0.11–1.55) | 0.37 (0.66–0.85) | |||
| Never smoker X pack-equivalent years | 4.26 (1.62–11.20)** | 3.10 (1.11–8.72) | |||
| Device type | |||||
| Cig-a-like device | 1.03 (0.86–1.24) | ||||
| Pod type device | 1.25 (1.08–1.45)** | ||||
| N | 1445 | 1059 | 156 | 2660 | 1795 |
All analysis show exponentiated coefficients after adjustment for respondent age, sex, education level, marital status, parental status, registration date, other daily drug use, province, and race; those who reported a diagnosis of asthma are excluded. Full tables with covariates available in (Supplementary file Table 1).
Pack-equivalent years is calculated as the number of reported puffs per day on days vaped (divided by 10, the standard number of puffs in a cigarette), multiplied by the number of days vaped per month (divided by 30 to provide an average daily use), then divided by 20 to convert to packs (20 cigarettes per pack) and finally multiplied by the number of years of vaping self-report (current age – age at when first started vaping).
p<0.05.
p<0.01.
p<0.001.